Two Phase 2 Trials to Assess Production of Dystrophin in Patients with Nonsense Mutation Duchenne Muscular Dystrophy Receiving Ataluren

被引：0
|
作者：
Nelson, S.
Penematsa, V
Chou, C.
Trifillis, P.
Bibbiani, F.
McIntosh, J.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
186
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 50 条
  • [41] Results of North Star Ambulatory Assessments (NSAA) in the Phase 3 Ataluren Confirmatory Trial in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (ACT DMD)
    Bushby, Katharine
    Kirschner, Jan
    Lu, Xiaohui
    Elfring, Gary
    Kroger, Hans
    Riebling, Peter
    Ong, Tuyen
    Spiegel, Robert
    Peltz, Stuart
    Muntoni, Francesco
    NEUROLOGY, 2016, 86
  • [42] Timed function tests and other physical function outcomes in Ataluren-treated patients with nonsense mutation Duchenne Muscular Dystrophy (nmDMD)
    McDonald, C.
    Reha, A.
    Elfring, G. L.
    Peitz, S. W.
    Spiegel, R.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 861 - 861
  • [43] Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry
    Delage, Abdallah
    Bucella, Filippo
    Desguerre, Isabelle
    Muntoni, Francesco
    Osorio, Andres Nascimento
    Tulinius, Mar
    Colucci, Salvatore
    Kristensen, Allan
    Santos, Claudio
    Schilling, Traci
    Trifillis, Panayiota
    Zhang, Olivia
    Mercuri, Eugenio
    NEUROLOGY, 2019, 92 (15)
  • [44] Novel image analysis to assess molecular functionality of dystrophin in Duchenne muscular dystrophy clinical trials
    Scaglioni, D.
    Catapano, F.
    Ellis, M.
    Torelli, S.
    Chambers, D.
    Feng, L.
    Husayni, S.
    Malhotra, J.
    Harriman, S.
    Koenig, E.
    Dugar, A.
    Steiner, D.
    Morgan, J.
    Phadke, R.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2020, 30 : S82 - S82
  • [45] Design of a confirmatory phase 3, multicentre, randomized, double-blind, placebo-controlled study of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
    Barth, J.
    Reha, A.
    Spiegel, R.
    Elfring, G. L.
    Husain, M.
    Peltz, S. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 201 - 201
  • [46] EFFECT OF ATALUREN ON AGE AT LOSS OF AMBULATION IN NONSENSE MUTATION DUCHENNE MUSCULAR DYSTROPHY: OBSERVATIONAL DATA FROM THE STRIDE REGISTRY
    Delage, Abdallah
    Buccella, Filippo
    Desguerre, Isabelle
    Muntoni, Francesco
    Nascimento, Andres
    Tulinius, Mar
    Colucci, Salvatore
    Kristensen, Allan
    Able, Rich
    Santos, Claudio
    Trifillis, Panayiota
    Zhang, Olivia
    Mercuri, E.
    MUSCLE & NERVE, 2019, 60 : S56 - S56
  • [47] Early Prenatal Detection of Mutation of Dystrophin Gene in Patients With Duchenne Muscular Dystrophy
    Abdrakhmanova, Zh U.
    Mahambetov, K. O.
    Abildinova, G. Zh
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (04): : 2056 - 2061
  • [48] Mutation Spectrum of Dystrophin Gene in Malaysian Patients with Duchenne/Becker Muscular Dystrophy
    Rani, Abdul Qawee
    Sasongko, Teguh Haryo
    Sulong, Sarina
    Bunyan, David
    Salmi, Abdul Razak
    Zilfalil, Bin Alwi
    Matsuo, Masafumi
    Zabidi-Hussin, Z. A. M. H.
    JOURNAL OF NEUROGENETICS, 2013, 27 (1-2) : 11 - 15
  • [49] Improvements in muscle function and accidental falling in Ataluren-treated patients with nonsense mutation dystrophinopathy (Duchenne/Becker Muscular Dystrophy - nmDBMD)
    Russman, B. S.
    Mathews, K. D.
    Sampson, J. B.
    Renfroe, J. B.
    Morsy, M. A.
    Elfring, G. L.
    Barth, J. A.
    Peltz, S. W.
    ANNALS OF NEUROLOGY, 2011, 70 : S172 - S172
  • [50] Timed Function Tests and Other Physical Function Outcomes in Ataluren-Treated Patients with Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
    McDonald, C.
    Reha, A.
    Elfring, G. L.
    Peltz, S. W.
    Spiegel, R. J.
    ANNALS OF NEUROLOGY, 2014, 76 : S236 - S237
12345